Evidence map›Paper›PMID 33417176›Full record

Observational studyIndian journal of gastroenterology : official journal of the Indian Society of Gastroenterology2021

Cognitive dysfunction in ulcerative colitis patients in remission and its comparison with patients with irritable bowel syndrome and healthy controls.

Neetu Sharma, Sanjay Dhiman, Vishal Bodh, Deepak Sharma, Rajesh Sharma, Sudhir Sharma, Brij Sharma

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Inflammatory bowel disease-associatedFrontiers in cellular and infection microbiology · 2022
    Article
  11. Editorial commentary on the Indian Journal of Gastroenterology - March-April 2021.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Neetu SharmaDepartment of Physiology, Indira Gandhi Medical College, Shimla, 171 001, India. naats.ns@gmail.com.
Sanjay DhimanDepartment of Physiology, Radhakrishnan Govt Medical College, Hamirpur, 171 001, India.
Vishal BodhDepartment of Gastroenterology, Indira Gandhi Medical College, Shimla, 177 001, India.
Deepak SharmaGovernment Medical College and Hospital, Chandigarh, 160 047, India.
Rajesh SharmaDepartment of Gastroenterology, Indira Gandhi Medical College, Shimla, 177 001, India.
Sudhir SharmaDepartment of Neurology, Indira Gandhi Medical College, Shimla, 177 001, India.
Brij SharmaDepartment of Gastroenterology, Indira Gandhi Medical College, Shimla, 177 001, India.
Indira Gandhi Medical College · INGovernment Medical College and Hospital · INNational Institute of Technology Hamirpur · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is a paucity of research concerning cognitive impairments in Inflammatory bowel disease - ulcerative colitis (IBD-UC) and irritable bowel syndrome (IBS). Studies on cognitive dysfunction in patients with IBD-UC have either been small or have shown conflicting results. This study is conducted to examine the evidence of cognitive dysfunction in IBD-UC patients in remission and compare the evident cognitive deficit with IBS patients and healthy controls.

methodsThis single-centre cross-sectional observational study enrolled a total of 90 participants, 29 in ulcerative colitis (UC) in remission group, 31 in IBS group and 30 in healthy control group. Assessment of cognition with the help of cognitive function tests mini-mental state examination (MMSE), Montreal Cognitive Assessment (MoCA) test and p300 was performed in all participants.

resultsA statistically significant number of the participants in IBD-UC in remission group had MMSE and MoCA score below the lower limit of normal, in comparison to the healthy control and IBS groups. The mean peak latency of the p300 wave was statistically significantly increased in people in the IBD-UC group, in comparison to the healthy control and IBS groups.

conclusionPatients with IBD-UC in remission show impairments in cognitive functioning compared to the IBS and healthy control groups as assessed on cognitive function testing on MMSE, MoCA and mean peak latency of the p300 wave. This impairment in cognitive function is unlikely to be due to premorbid levels of intellectual functioning and is likely to have impact on health-related quality of life.

Indexed as

Cognitive DysfunctionColitis, UlcerativeInflammatory Bowel DiseasesIrritable Bowel SyndromeCross-Sectional StudiesHumansQuality of LifeCrohn diseaseEvent-related potentialsHealth-related quality of lifeInflammatory bowel diseaseIrritable bowel syndromeMild cognitive impairmentMini-mental status examinationMontreal Cognitive AssessmentUlcerative colitis

Identifiers

PMID33417176
OpenAlexW3119879034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.